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HTLV-1 is responsible for two main diseases, Adult T-cell
Leukemia/Lymphoma and HTLV-1 Associated Myelopathy/
Tropical Spastic Paraparesis, for which there is currently no
satisfactory treatment. Among the proteins encoded by
HTLV-1, Tax appears to play an important role in the
mechanisms leading to pathogenicity. We are interested in
the mechanisms of cell transformation by Tax and more
particularly in the interplay between the viral Tax oncopro-
tein and the DNA damage response (DDR). We demon-
strated that transient expression of Tax results in DNA
damage, cell cycle arrest and activation of the DDR. In fibro-
blasts, cell cycle arrest occurs at the G1 and G2 phases
depending on the p53 background. Although Tax induces
apoptosis and senescence in fibroblasts, HTLV-1 infected
lymphocytes proliferate continuously and appear to be
adapted to the checkpoint control. This mechanism allows
infected lymphocytes to proliferate despite the presence of
genomic lesions. With these observations, we propose a
novel therapeutic approach based on the principle of syn-
thetic lethality.
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